Product Details
TRANEXAMIC ACID 650MG TB 30/EA
Manufacturer: AMRING PHARMACEUTICALS
MFG#: 69918-0301-30
NDC: 69918-0301-30
PID: 246105
UN
$ *.**
In StockAdditional Information
| Product Name | Tranexamic Acid 650 mg Tablet |
| Application | Antifibrinolytic Agent |
| Generic Drug Name | Tranexamic Acid |
| Mechanism of action | Inhibits plasminogen activation to plasmin, preventing fibrinolysis |
| Quantity | 30 Tablets |
| Strength | 650 mg |
| Onset of Action | Within 3 hours of oral administration |
| Route of Administration | Oral |
| Half-life | Approximately 3 hours |
| Side Effects | Nausea, vomiting, diarrhea, headache, dizziness |
| Contraindications | Active thromboembolic disease, hypersensitivity to tranexamic acid |
| Pregnancy Category | Category B |
| Primary Use | Control of excessive bleeding (e.g., in surgery, trauma, menorrhagia) |
Description
Tranexamic Acid 650 mg tablets are an antifibrinolytic agent indicated for the treatment and prevention of excessive bleeding. It is commonly used in patients undergoing surgery, trauma, or those with bleeding disorders such as menorrhagia (heavy menstrual bleeding). Tranexamic acid works by inhibiting the activation of plasminogen to plasmin, thereby preventing fibrinolysis (the breakdown of fibrin in blood clots).
The drug is administered orally and is typically prescribed for short-term use, depending on the clinical condition and response. The typical dosage of tranexamic acid for managing heavy menstrual bleeding is 1300 mg per day for up to 5 days. For surgical bleeding, the dose and duration are adjusted according to the patient's condition and the nature of the procedure.
Common side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Tranexamic acid should be used with caution in patients with renal impairment due to the risk of accumulation. It is also contraindicated in patients with active thromboembolic disease or those at high risk for blood clots.
Product Properties:
| Description | I |
|---|---|
| Description | I |
| DESI Drug Ind | $3.47; 04/01/2017 |
| DESI Drug Ind | $3.47; 04/01/2017 |
| Drug Category | USES: This medication is used to treat heavy bleeding during your menstrual period. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases. |
| Drug Category | USES: This medication is used to treat heavy bleeding during your menstrual period. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases. |
| Drug Type Code | COMMON BRAND NAME(S): Lysteda |
| Drug Type Code | COMMON BRAND NAME(S): Lysteda |
| HCPCS | 1 |
| HCPCS | 1 |
| Medical Coverage | - |
| Medical Coverage | - |
| Termination Date | (TRAN-ex-AM-ik AS-id) |
| Termination Date | (TRAN-ex-AM-ik AS-id) |
| Active Ingredients | 2073 tranexamic acid 1197188 |
| Active Ingredients | 2073 tranexamic acid 1197188 |
| AHFS Class | 20281600 HEMOSTATICS |
| AHFS Class | 20281600 HEMOSTATICS |
| DEA Class | NC |
| DEA Class | NC |
| Dose Form | TABLET |
| Dose Form | TABLET |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 66336 tranexamic acid ORAL TABLET 650 MG |
| Gen Code and Des | 66336 tranexamic acid ORAL TABLET 650 MG |
| Inactive Ingredients | 2537 povidone 9003398 |
| Inactive Ingredients | 2537 povidone 9003398 |
| OMP Family | - |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Strength | 650MG |
| Strength | 650MG |
| Common Brand Name | - |
| Common Brand Name | - |
| Drug Interaction | - |
| Drug Interaction | - |
| Allocation Period | - |
| Allocation Period | - |
| Case Quantity | 12 |
| Case Quantity | 12 |
| Drug Form Pack Size | 30 |
| Drug Form Pack Size | 30 |
| Form | TABLET |
| Form | TABLET |
| Hazard Code | - |
| Hazard Code | - |
| Listed Chemical | - |
| Listed Chemical | - |
| NIOSH Code | - |
| NIOSH Code | - |
| Orange Book | AB Products meeting necessary bioequivalence requirements. |
| Orange Book | AB Products meeting necessary bioequivalence requirements. |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Returnable Status | Returnable |
| Returnable Status | Returnable |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit | EA |
| Unit Size | 30 |
| Unit Size | 30 |
| How to Use | - |
| How to Use | - |
| Missed Dose | 30 |
| Missed Dose | 30 |
| Notes | TAB |
| Notes | TAB |
| Overdose | AB |
| Overdose | AB |
| Phonetic Pronunciation | - |
| Phonetic Pronunciation | - |
| Precautions | - |
| Precautions | - |
| Side Effects | - |
| Side Effects | - |
| Storage | 11/13/2009 |
| Storage | 11/13/2009 |
| Uses | - |
| Uses | - |
Frequently Asked Questions (FAQs)
The cost of TRANEXAMIC ACID 650MG TB 30/EA is $$0.00
TRANEXAMIC ACID 650MG TB 30/EA is manufactured by AMRING PHARMACEUTICALS.
You can purchase TRANEXAMIC ACID 650MG TB 30/EA on our website at https://supplies.pipelinemedical.com/product/detail/tranexamic-acid-650-mg-tab-30-246105